Search

Your search keyword '"Swann JW"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Swann JW" Remove constraint Author: "Swann JW"
159 results on '"Swann JW"'

Search Results

1. Canine autoimmune hemolytic anemia: management challenges

2. Stromal niche inflammation mediated by IL-1 signaling is a targetable driver of hematopoietic aging

3. Investigation of type 2 cytokine pathways as modulators of haematopoiesis during chronic inflammation

4. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats

5. Is there a 'best way' to treat immune-mediated hemolytic anemia in dogs?

12. Eosinophilia and lichenification of the skin

13. Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche.

14. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production.

15. Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells.

16. Maternal inflammation regulates fetal emergency myelopoiesis.

17. Comparison of timing of relapse in dogs with nonassociative immune-mediated hemolytic anemia, thrombocytopenia, or polyarthritis.

18. Maternal IL-10 restricts fetal emergency myelopoiesis.

19. Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells.

20. Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production.

21. PAK1 c.1409 T > a (p. Leu470Gln) de novo variant affects the protein kinase domain, leading to epilepsy, macrocephaly, spastic quadriplegia, and hydrocephalus: Case report and review of the literature.

22. Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing.

23. Neurobehavioral deficits and a progressive ictogenesis in the tetrodotoxin model of epileptic spasms.

24. Investigation of single-nucleotide polymorphisms in the NR3C1a glucocorticoid receptor gene in Cocker Spaniels with primary immune thrombocytopenia.

25. Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.

26. A Role for Insulin-like Growth Factor 1 in the Generation of Epileptic Spasms in a murine model.

27. Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.

28. Brain state-dependent high-frequency activity as a biomarker for abnormal neocortical networks in an epileptic spasms animal model.

29. Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms.

30. Neocortical Slow Oscillations Implicated in the Generation of Epileptic Spasms.

31. Breed predispositions, clinical findings, and prognostic factors for death in dogs with nonregenerative immune-mediated anemia.

32. Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care.

33. IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors.

34. Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy.

35. GM-CSF drives dysregulated hematopoietic stem cell activity and pathogenic extramedullary myelopoiesis in experimental spondyloarthritis.

36. Randomised controlled trial of fractionated and unfractionated prednisolone regimens for dogs with immune-mediated haemolytic anaemia.

37. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.

38. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.

39. PTEN Loss Increases the Connectivity of Fast Synaptic Motifs and Functional Connectivity in a Developing Hippocampal Network.

40. The Impact of Electrographic Seizures on Developing Hippocampal Dendrites Is Calcineurin Dependent.

41. Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia.

42. Prevalence and risk factors for development of hemorrhagic gastro-intestinal disease in veterinary intensive care units in the United Kingdom.

43. Canine babesiosis: autochthonous today, endemic tomorrow?

44. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.

45. Novel immunotherapies for immune-mediated haemolytic anaemia in dogs and people.

46. Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia.

47. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides.

48. Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes.

49. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms.

50. Histologic and clinical features of primary and secondary vasculitis: a retrospective study of 42 dogs (2004-2011).

Catalog

Books, media, physical & digital resources